Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Radformation
AddedFeb 15, 2024
UpdatedJun 18, 2026
Radformation

Radformation

Radformation: Innovating efficient, error-reducing software for radiation oncology cancer treatment planning.

HQ
New York City, NY, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Radformation was founded by a team of clinical physicists with the core mission of increasing efficiency and reducing errors in radiation oncology cancer treatment planning. The company offers innovative software solutions designed to automate and streamline various stages of the treatment planning process, including contouring, planning, and quality assurance. Their products aim to enhance plan quality, safety, and overall departmental efficiency, allowing cancer clinics to focus more on patient care.

Notable affiliated individuals include the founding team of clinical physicists who bring extensive expertise in radiation oncology. Radformation has received investments from prominent venture capital firms specializing in healthcare technology. Key achievements include the successful deployment of their software in numerous cancer treatment centers, significantly improving workflow and reducing planning time. The overall impact of Radformation's solutions is seen in enhanced treatment accuracy and increased capacity for clinics to manage complex cases efficiently.

Radformation - Similar Companies

Radialogica logo

Radialogica

radialogica.com

RAD AI logo

RAD AI

radai.com

OncoLens logo

OncoLens

oncolens.com

Infondrian logo

Infondrian

infondrian.com

RadUnity logo

RadUnity

radunity.com

RadLogics logo

RadLogics

radlogics.com

Quantaras logo

Quantaras

quantaras.com

Redox logo

Redox

redoxengine.com

Oncospace logo

Oncospace

oncospace.com

Voximetry logo

Voximetry

voximetry.com

RxVantage logo

RxVantage

rxvantage.com

Radionetics Oncology logo

Radionetics Oncology

radionetics.com

Clinetic logo

Clinetic

clinetic.com

Radicai logo

Radicai

radicai.com

Radial Analytics logo

Radial Analytics

Radformation - Quick Facts

Who are Radformation's competitors?

Companies similar to Radformation include Radialogica, RAD AI, OncoLens and Infondrian.

When was Radformation founded?

Radformation was founded in 2016.

Where is Radformation's headquarters located?

Radformation's headquarters is located in New York City, NY, US.

When was Radformation's last funding round?

Radformation's most recent funding round was for $6.9M (USD) in May 2023.

How much has Radformation raised to-date?

As of May 25, 2023, Radformation has raised a total of $8.5M (USD).

How many employees does Radformation have?

Radformation has 119 employees as of Feb 5, 2024.

Radformation - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Software
Tags
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified